688796 百奥赛图
已收盘 09-24 15:00:00
资讯
新帖
简况
百奥赛图（688796）9月24日主力资金净卖出4735.87万元
证券之星 · 09-25 08:23
百奥赛图（688796）9月24日主力资金净卖出4735.87万元
9月24日百奥赛图跌6.61%，富国精准医疗混合A基金重仓该股
证券之星 · 09-24 16:39
9月24日百奥赛图跌6.61%，富国精准医疗混合A基金重仓该股
研报掘金丨浙商证券：首予百奥赛图“买入”评级，全球领先的抗体发现赋能平台
格隆汇 · 09-20
研报掘金丨浙商证券：首予百奥赛图“买入”评级，全球领先的抗体发现赋能平台
9月18日百奥赛图涨6.08%，富国精准医疗混合A基金重仓该股
证券之星 · 09-18
9月18日百奥赛图涨6.08%，富国精准医疗混合A基金重仓该股
CRO概念股午前涨幅居前 金斯瑞生物科技涨超16%百奥赛图-B涨超6%
新浪港股 · 09-17
CRO概念股午前涨幅居前 金斯瑞生物科技涨超16%百奥赛图-B涨超6%
百奥赛图：2026年第三次临时股东会决议公告
同花顺 · 09-16
百奥赛图：2026年第三次临时股东会决议公告
百奥赛图：调整药物早期研发服务平台募投项目
同花顺 · 09-16
百奥赛图：调整药物早期研发服务平台募投项目
港股异动 | 百奥赛图-B(02315)涨超6% 行业景气度持续高涨 动物模型及临床前药效业务维持高增
智通财经 · 09-14
港股异动 | 百奥赛图-B(02315)涨超6% 行业景气度持续高涨 动物模型及临床前药效业务维持高增
股市必读：百奥赛图新发布《港股公告：证券变动月报表》
证券之星 · 09-14
股市必读：百奥赛图新发布《港股公告：证券变动月报表》
百奥赛图（688796）披露证券变动月报表，9月11日股价下跌1.71%
证券之星 · 09-11
百奥赛图（688796）披露证券变动月报表，9月11日股价下跌1.71%
百奥赛图上半年归母净利润2.41亿元 同比增长402.29%
同花顺 · 09-11
百奥赛图上半年归母净利润2.41亿元 同比增长402.29%
百奥赛图：2025年归属于上市公司股东的净利润17,319.98万元
证券之星 · 09-11
百奥赛图：2025年归属于上市公司股东的净利润17,319.98万元
百奥赛图：9月9日召开业绩说明会，投资者参与
证券之星 · 09-11
百奥赛图：9月9日召开业绩说明会，投资者参与
9月8日百奥赛图涨7.76%，富国精准医疗混合A基金重仓该股
证券之星 · 09-08
9月8日百奥赛图涨7.76%，富国精准医疗混合A基金重仓该股
港股异动 | 百奥赛图-B(02315)午后涨超10% 与齐鲁制药签署全人纳米抗体分子非排他授权合作协议
智通财经 · 09-08
港股异动 | 百奥赛图-B(02315)午后涨超10% 与齐鲁制药签署全人纳米抗体分子非排他授权合作协议
港股生物医药股午后走强，剂泰科技-P涨近15%，百奥赛图-B、金斯瑞生物科技涨近10%
老虎资讯综合 · 09-08
港股生物医药股午后走强，剂泰科技-P涨近15%，百奥赛图-B、金斯瑞生物科技涨近10%
每周股票复盘：百奥赛图（688796）将召开2026年半年度业绩说明会
证券之星 · 09-06
每周股票复盘：百奥赛图（688796）将召开2026年半年度业绩说明会
百奥赛图-B(02315.HK)获富国基金增持95万股
中金财经 · 09-04
百奥赛图-B(02315.HK)获富国基金增持95万股
9月4日百奥赛图跌5.66%，富国精准医疗混合A基金重仓该股
证券之星 · 09-04
9月4日百奥赛图跌5.66%，富国精准医疗混合A基金重仓该股
百奥赛图与齐鲁制药达成全人纳米抗体分子非排他授权合作，支持神经领域创新药物开发
美通社 · 09-03
百奥赛图与齐鲁制药达成全人纳米抗体分子非排他授权合作，支持神经领域创新药物开发
加载更多
公司概况
公司名称：
百奥赛图(北京)医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2025-12-10
主营业务：
百奥赛图(北京)医药科技股份有限公司的主营业务是CRO行业细分领域中的临床前CRO，以及抗体药物的研发。公司的主要产品是基因编辑服务、创新模式动物销售、临床前药理药效评价服务、抗体开发、创新药合作研发。
发行价格：
26.68
{"stockData":{"symbol":"688796","market":"SH","secType":"STK","nameCN":"百奥赛图","latestPrice":126.54,"timestamp":1790233200000,"preClose":135.5,"halted":0,"volume":2602992,"delay":0,"changeRate":-0.0661,"floatShares":38607500,"shares":447000000,"eps":0.8197,"marketStatus":"已收盘","change":-8.96,"latestTime":"09-24 15:00:00","open":135.5,"high":135.5,"low":126,"amount":336000000,"amplitude":0.0701,"askPrice":126.54,"askSize":73,"bidPrice":126.5,"bidSize":25,"shortable":0,"etf":0,"ttmEps":0.8197,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790559000000},"marketStatusCode":5,"adr":0,"adjPreClose":135.5,"symbolType":"stock_kcb","openAndCloseTimeList":[[1790213400000,1790220600000],[1790226000000,1790233200000]],"highLimit":149.05,"lowLimit":121.95,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":446898420,"isCdr":false,"pbRate":23.35,"roa":"--","peRate":154.373551,"roe":"10.49%","epsLYR":0.43,"committee":-0.596491,"marketValue":56551000000,"turnoverRate":0.0674,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-09-28。","afterMarket":{"amount":126540,"volume":1000,"close":126.54,"buyVolume":0,"sellVolume":3197,"time":1790235237746,"indexStatus":"已收盘 09-24 15:30:00","preClose":135.5},"hkstockBrief":{"symbol":"02315","market":"HK","secType":"STK","nameCN":"百奥赛图-B","latestPrice":68.3,"timestamp":1790323694004,"preClose":67.65,"halted":0,"volume":191000,"delay":0,"premium":"-53.72"},"floatMarketCap":4885000000},"requestUrl":"/m/hq/s/688796","defaultTab":"news","newsList":[{"id":"2670959419","title":"百奥赛图（688796）9月24日主力资金净卖出4735.87万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670959419","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670959419?lang=zh_cn&edition=full","pubTime":"2026-09-25 08:23","pubTimestamp":1790295791,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月24日收盘，百奥赛图报收于126.54元，下跌6.61%，换手率6.74%，成交量2.6万手，成交额3.36亿元。近5日资金流向一览见下表：百奥赛图融资融券信息显示，融资方面，当日融资买入2652.88万元，融资偿还3790.33万元，融资净偿还1137.45万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092500005089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688796","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669463262","title":"9月24日百奥赛图跌6.61%，富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669463262","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669463262?lang=zh_cn&edition=full","pubTime":"2026-09-24 16:39","pubTimestamp":1790239196,"startTime":"0","endTime":"0","summary":"证券之星消息，9月24日百奥赛图跌6.61%，收盘报126.54元，换手率6.74%，成交量2.6万手，成交额3.36亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共40家，其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为28.98亿元，最新净值3.368，较上一交易日上涨0.24%，近一年下跌3.06%。富国精准医疗混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400028575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668185534","title":"研报掘金丨浙商证券：首予百奥赛图“买入”评级，全球领先的抗体发现赋能平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2668185534","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668185534?lang=zh_cn&edition=full","pubTime":"2026-09-20 16:44","pubTimestamp":1789893890,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["688796","BK0216","BK0276","601878"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668418589","title":"9月18日百奥赛图涨6.08%，富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2668418589","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668418589?lang=zh_cn&edition=full","pubTime":"2026-09-18 16:44","pubTimestamp":1789721068,"startTime":"0","endTime":"0","summary":"证券之星消息，9月18日百奥赛图涨6.08%，收盘报134.27元，换手率10.77%，成交量4.16万手，成交额5.52亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共40家，其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为28.98亿元，最新净值3.1941，较上一交易日下跌0.11%，近一年下跌9.99%。富国精准医疗混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091800025907.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668953595","title":"CRO概念股午前涨幅居前 金斯瑞生物科技涨超16%百奥赛图-B涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668953595","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668953595?lang=zh_cn&edition=full","pubTime":"2026-09-17 11:38","pubTimestamp":1789616280,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端CRO概念股午前涨幅居前，截至发稿，金斯瑞生物科技（01548）上涨16.28%，报37.86港元；百奥赛图-B（02315）上涨6.14%，报62.20港元；维亚生物（01873）上涨5.95%，报1.425港元；凯莱英（06821）上涨3.28%，报169.90港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-17/doc-iniscekc4123625.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","HK0000306685.HKD","BK1141","BK1583","BK1576","BK0216","HK0000320264.USD","HK0000320223.HKD","01548","02315","688796","HK0000306701.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667983034","title":"百奥赛图：2026年第三次临时股东会决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2667983034","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667983034?lang=zh_cn&edition=full","pubTime":"2026-09-16 20:32","pubTimestamp":1789561920,"startTime":"0","endTime":"0","summary":" 证券日报网讯 9月16日，百奥赛图发布公告称，公司于2026年9月16日召开2026年第三次临时股东会，审议通过《关于变更部分募投项目实施方式的议案》。 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260916/c679981145.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260916/c679981145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["688796","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667602659","title":"百奥赛图：调整药物早期研发服务平台募投项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2667602659","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667602659?lang=zh_cn&edition=full","pubTime":"2026-09-16 18:05","pubTimestamp":1789553100,"startTime":"0","endTime":"0","summary":"9月16日，百奥赛图(688796.SH)公告称，公司拟调整首次公开发行股票募投项目“药物早期研发服务平台建设项目”，投资总额由4.54亿元增至4.62亿元，新增800万元由自有资金投入，拟投入募集资 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260916/c679976149.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260916/c679976149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK0216","688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667554306","title":"港股异动 | 百奥赛图-B(02315)涨超6% 行业景气度持续高涨 动物模型及临床前药效业务维持高增","url":"https://stock-news.laohu8.com/highlight/detail?id=2667554306","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667554306?lang=zh_cn&edition=full","pubTime":"2026-09-14 15:31","pubTimestamp":1789371077,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百奥赛图-B涨超6%，截至发稿，涨6.24%，报59.6港元，成交额8729.41万港元。消息面上，今年上半年，百奥赛图实现营收9.4亿元，同比增长51.6%；归母净利润2.4亿元，同比大增402%。与此同时，本月初，百奥赛图宣布与齐鲁制药达成全人纳米抗体分子非排他授权合作，支持神经领域创新药物开发。中邮证券指出，行业景气度持续高涨叠加海外拓展共振，动物模型+临床前药效业务维持高增。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495580.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4585","02315","VXUS","KCAI","688796","BK0216","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667800166","title":"股市必读：百奥赛图新发布《港股公告：证券变动月报表》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667800166","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667800166?lang=zh_cn&edition=full","pubTime":"2026-09-14 02:45","pubTimestamp":1789325113,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，百奥赛图报收于120.4元，下跌1.71%，换手率6.63%，成交量2.56万手，成交额3.04亿元。公司公告汇总：截至2026年8月31日，百奥赛图H股与A股已发行股份均无变动，H股结存110,781,920股，A股结存336,116,500股。公司公告汇总港股公告：证券变动月报表百奥赛图(北京)医药科技股份有限公司提交截至2026年8月31日的证券变动月报表。具体以年报披露为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001096.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688796","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666695578","title":"百奥赛图（688796）披露证券变动月报表，9月11日股价下跌1.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666695578","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666695578?lang=zh_cn&edition=full","pubTime":"2026-09-11 22:29","pubTimestamp":1789136982,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，百奥赛图报收于120.4元，较前一交易日下跌1.71%，最新总市值为538.07亿元。该股当日开盘122.0元，最高122.46元，最低114.0元，成交额达3.04亿元，换手率为6.63%。近日，百奥赛图(北京)医药科技股份有限公司提交截至2026年8月31日的证券变动月报表。A股于上海证券交易所科创板上市，证券代码688796，上月底结存及本月底结存均为336,116,500股，每股面值人民币1元。公司确认已符合香港联交所规定的公众持股量要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100050525.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688796","BK0216","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666521767","title":"百奥赛图上半年归母净利润2.41亿元 同比增长402.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666521767","media":"同花顺","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666521767?lang=zh_cn&edition=full","pubTime":"2026-09-11 19:50","pubTimestamp":1789127400,"startTime":"0","endTime":"0","summary":"9月11日，百奥赛图-B(02315.HK)发布2026年半年度持续督导跟踪报告。2026年上半年，公司实现营业收入9.41亿元，同比增长51.60%；利润总额2.49亿元，同比增长316.93%；归属于上市公司股东的净 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260911/c679839135.shtml","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260911/c679839135.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666358523","title":"百奥赛图：2025年归属于上市公司股东的净利润17,319.98万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666358523","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666358523?lang=zh_cn&edition=full","pubTime":"2026-09-11 17:42","pubTimestamp":1789119735,"startTime":"0","endTime":"0","summary":"证券之星消息，百奥赛图(688796)09月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司25年年报显示未分配利润—15.7亿元，是否说明到25年年底，公司尚未真正盈利？百奥赛图回复：感谢您的关注。公司2025年归属于上市公司股东的净利润17,319.98万元，同比增长416.37%；其中归属于上市公司股东的扣除非经常性损益的净利润11,607.78万元，同比增长405.39%。具体以年报披露为准。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100038798.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666654660","title":"百奥赛图：9月9日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2666654660","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666654660?lang=zh_cn&edition=full","pubTime":"2026-09-11 14:06","pubTimestamp":1789106778,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年9月10日百奥赛图发布公告称公司于2026年9月9日召开业绩说明会。公司2026年上半年归属于上市公司股东的净利润24,109.44万元，较去年同期增长402.29%；其中归属于上市公司股东的扣除非经常性损益的净利润19,744.58万元，较去年同期增长591.53%。其中，2026年上半年新增签署协议超105项。2026年上半年，以创新动物模型销售为核心的临床前产品与服务业务实现营业收入72,349.19万元，较去年同期增长57.94%，同时毛利率保持在约75.22%的高水平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100028122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665907325","title":"9月8日百奥赛图涨7.76%，富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665907325","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665907325?lang=zh_cn&edition=full","pubTime":"2026-09-08 16:40","pubTimestamp":1788856838,"startTime":"0","endTime":"0","summary":"证券之星消息，9月8日百奥赛图涨7.76%，收盘报128.56元，换手率11.48%，成交量4.43万手，成交额5.48亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共40家，其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为28.98亿元，最新净值3.3282，较上一交易日下跌0.62%，近一年下跌11.99%。富国精准医疗混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800026135.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665934210","title":"港股异动 | 百奥赛图-B(02315)午后涨超10% 与齐鲁制药签署全人纳米抗体分子非排他授权合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2665934210","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665934210?lang=zh_cn&edition=full","pubTime":"2026-09-08 13:53","pubTimestamp":1788846789,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百奥赛图-B午后涨超10%，截至发稿，涨8.71%，报63港元，成交额1.29亿港元。消息面上，据百奥赛图官微消息，公司宣布近期与齐鲁制药签署全人纳米抗体分子非排他授权合作协议。本次合作涉及的纳米抗体分子由百奥赛图自主研发的RenNano纳米抗体平台产生。通过此次授权，齐鲁制药可结合其自身研发策略，对相关纳米抗体分子开展进一步研究和开发，后续项目的开发形式将根据项目特点和治疗需求灵活推进。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493233.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688796","BK1191","VXUS","BK1161","BK4588","BK1574","BK0216","KCAI","BK4585","02315","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113703587","title":"港股生物医药股午后走强，剂泰科技-P涨近15%，百奥赛图-B、金斯瑞生物科技涨近10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113703587","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113703587?lang=zh_cn&edition=full","pubTime":"2026-09-08 13:33","pubTimestamp":1788845625,"startTime":"0","endTime":"0","summary":"9月8日，港股$生物(000504)$医药股午后走强，$剂泰科技-P(07666)$涨近15%，$百奥赛图-B(02315)$、$金斯瑞生物科技(01548)$涨近10%，$泰格医药(03347)$、$康希诺生物(06185)$、$云顶新耀(01952)$涨超5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK1161","HK0000306701.USD","02315","01952","HK0000306685.HKD","BK1574","01548","688796","399441","BK1583","BK1515","03347","BK0216","BK4581","HK0000320223.HKD","161726","BK1191","06185","BK1141","KCAI","BK1576","BK4585","BK4588","09939","07666","HK0000320264.USD","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665365516","title":"每周股票复盘：百奥赛图（688796）将召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2665365516","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665365516?lang=zh_cn&edition=full","pubTime":"2026-09-06 01:32","pubTimestamp":1788629531,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，百奥赛图报收于119.89元，较上周的116.91元上涨2.55%。本周，百奥赛图9月3日盘中最高价报129.55元。本周关注点公司公告汇总：百奥赛图将于2026年9月9日召开半年度业绩说明会。公司公告汇总百奥赛图（北京）医药科技股份有限公司将于2026年9月9日16:30-17:30通过进门财经平台以网络文字互动方式召开2026年半年度业绩说明会，介绍公司上半年经营成果及财务状况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000264.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688796","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664330266","title":"百奥赛图-B(02315.HK)获富国基金增持95万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664330266","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664330266?lang=zh_cn&edition=full","pubTime":"2026-09-04 22:47","pubTimestamp":1788533225,"startTime":"0","endTime":"0","summary":"格隆汇6月4日丨根据联交所最新权益披露资料显示，2026年6月1日，百奥赛图-B(02315.HK)获富国基金管理有限公司在场内以每股均价45.1061港元增持95万股，涉资约4285.1万港元。\r\n\r\n 增持后，富国基金管理有限公司最新持股数目为666.17万股，持股比例由5.18%上升至6.01%。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/04/20260904471142.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/04/20260904471142.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260904/32360964.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0216","BK1161","688796","02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664809353","title":"9月4日百奥赛图跌5.66%，富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664809353","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664809353?lang=zh_cn&edition=full","pubTime":"2026-09-04 16:36","pubTimestamp":1788511008,"startTime":"0","endTime":"0","summary":"证券之星消息，9月4日百奥赛图跌5.66%，收盘报119.89元，换手率6.61%，成交量2.55万手，成交额3.13亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共40家，其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为28.98亿元，最新净值3.3539，较上一交易日上涨1.79%，近一年下跌10.98%。富国精准医疗混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400029037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664782740","title":"百奥赛图与齐鲁制药达成全人纳米抗体分子非排他授权合作，支持神经领域创新药物开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2664782740","media":"美通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664782740?lang=zh_cn&edition=full","pubTime":"2026-09-03 14:23","pubTimestamp":1788416580,"startTime":"0","endTime":"0","summary":"北京2026年9月3日 /美通社/ -- 百奥赛图（北京）医药科技股份有限公司于2026年9月2日宣布，公司近期与齐鲁制药有限公司签署全人纳米抗体分子非排他授权合作协议。根据协议，百奥赛图将向齐鲁制药授权一款全人纳米抗体分子，用于支持其在神经领域创新药物项目中的研发探索。通过此次授权，齐鲁制药可结合其自身研发策略，对相关纳米抗体分子开展进一步研究和开发，后续项目的开发形式将根据项目特点和治疗需求灵活推进。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5039953_ZH39953_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5039953_ZH39953_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["01477","LNGR","BK1574","06978","BK1161","02315","MEDX","BK1191","688796","IBBQ","BK0216"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790443711992,"stockEarnings":[{"period":"1week","weight":-0.0003},{"period":"1month","weight":0.0152},{"period":"3month","weight":0.3735},{"period":"6month","weight":0.3624},{"period":"1year","weight":3.7429},{"period":"ytd","weight":1.4057}],"compareEarnings":[{"period":"1week","weight":0.0033},{"period":"1month","weight":-0.0003},{"period":"3month","weight":-0.0345},{"period":"6month","weight":-0.0065},{"period":"1year","weight":0.009},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"百奥赛图(北京)医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"0人","perCapita":"--","listingDate":"2025-12-10","address":"北京市大兴区中关村科技园区大兴生物医药产业基地宝参南街12号院","registeredCapital":"44689万元","survey":" 百奥赛图(北京)医药科技股份有限公司的主营业务是CRO行业细分领域中的临床前CRO，以及抗体药物的研发。公司的主要产品是基因编辑服务、创新模式动物销售、临床前药理药效评价服务、抗体开发、创新药合作研发。","listedPrice":26.68},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百奥赛图(688796)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百奥赛图(688796)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百奥赛图,688796,百奥赛图股票,百奥赛图股票老虎,百奥赛图股票老虎国际,百奥赛图行情,百奥赛图股票行情,百奥赛图股价,百奥赛图股市,百奥赛图股票价格,百奥赛图股票交易,百奥赛图股票购买,百奥赛图股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百奥赛图(688796)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百奥赛图(688796)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}